Publicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (22)

2020

  1. Endothelin-1-mediated drug resistance in EGFR-mutant non-small cell lung carcinoma

    Cancer Research, Vol. 80, Núm. 19, pp. 4224-4232

  2. Extracellular Vesicles From Liver Progenitor Cells Downregulates Fibroblast Metabolic Activity and Increase the Expression of Immune-Response Related Molecules

    Frontiers in Cell and Developmental Biology, Vol. 8

  3. Plasma-derived extracellular vesicles from Plasmodium vivax patients signal spleen fibroblasts via NF-kB facilitating parasite cytoadherence

    Nature Communications, Vol. 11, Núm. 1

2019

  1. CXCR7 reactivates ERK signaling to promote resistance to EGFR kinase inhibitors in NSCLC

    Cancer Research, Vol. 79, Núm. 17, pp. 4439-4452

  2. The red blood cell proportion of arachidonic acid relates to shorter leukocyte telomeres in Mediterranean elders: A secondary analysis of a randomized controlled trial

    Clinical Nutrition, Vol. 38, Núm. 2, pp. 958-961

2018

  1. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Journal of Extracellular Vesicles, Vol. 7, Núm. 1

  2. PanDrugs: A novel method to prioritize anticancer drug treatments according to individual genomic data

    Genome Medicine, Vol. 10, Núm. 1

2017

  1. Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition

    Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. Intratumoral heterogeneity in EGFR-mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition

    Cancer Research, Vol. 75, Núm. 20, pp. 4372-4383

2014

  1. Endothelial NT-3 Delivered by Vasculature and CSF Promotes Quiescence of Subependymal Neural Stem Cells through Nitric Oxide Induction

    Neuron, Vol. 83, Núm. 3, pp. 572-585

  2. Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor

    Cancer Cell, Vol. 26, Núm. 6, pp. 909-922

2013

  1. Analysis of cytotoxic activity at short incubation times reveals profound differences among Annonaceus acetogenins, inhibitors of mitochondrial Complex i

    Journal of Bioenergetics and Biomembranes, Vol. 45, Núm. 1-2, pp. 145-152

2012

  1. Epigenetic biomarkers: A new perspective in laboratory diagnostics

    Clinica Chimica Acta, Vol. 413, Núm. 19-20, pp. 1576-1582

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2007

  1. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer

    Oncogene, Vol. 26, Núm. 11, pp. 1616-1625

2005

  1. Acceleration of glutathione efflux and inhibition of γ- glutamyltranspeptidase sensitize metastatic B16 melanoma cells to endothelium-induced cytotoxicity

    Journal of Biological Chemistry, Vol. 280, Núm. 8, pp. 6950-6959

  2. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells

    Human Molecular Genetics, Vol. 14, Núm. 7, pp. 973-982

2004

  1. Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations

    Oncogene, Vol. 23, Núm. 29, pp. 5084-5091